"Located next to the Crozer Medical Plaza and connected to it by a walkway, the Crozer Medical Plaza and Crozer-Keystone Cancer Center is an outpatient facility offering state-of-the-art patient care."

During the past decade, Crozer Regional Cancer Center at Brinton Lake conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 2 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Crozer Regional Cancer Center at Brinton Lake" #1 sponsor was "NRG Oncology" with 6 trials, followed by "National Cancer Institute (NCI)" with 6 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored and "SWOG Cancer Research Network" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Crozer Regional Cancer Center at Brinton Lake" #1 collaborator was "National Cancer Institute (NCI)" with 10 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator, "Division of Cancer Control" with 1 trials as a collaborator and "NIH Biomarker, Imaging and Quality of Life Studies Funding Program (BIQSFP)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Crozer Regional Cancer Center at Brinton Lake" are "Metastatic Malignant Neoplasm in the Brain" (2 trials), "Prostate Adenocarcinoma" (2 trials), "Stage I Prostate Adenocarcinoma" (2 trials), "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (2 trials) and "Stage II Lung Non-Small Cell Cancer AJCC v7" (2 trials). Many other conditions were trialed in "Crozer Regional Cancer Center at Brinton Lake" in a lesser frequency.

Most popular intervention types in "Crozer Regional Cancer Center at Brinton Lake" are "Drug" (14 trials), "Other" (12 trials), "Radiation" (8 trials), "Biological" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (5 trials), "Placebo Administration" (4 trials), "Quality-of-Life Assessment" (4 trials), "Cisplatin" (3 trials) and "Clinical Observation" (3 trials). Other intervention names were less common.

The vast majority of trials in "Crozer Regional Cancer Center at Brinton Lake" are 12 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Crozer Regional Cancer Center at Brinton Lake". undefined are not yet recruiting, 5 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Crozer Regional Cancer Center at Brinton Lake, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Crozer Regional Cancer Center at Brinton Lake, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".